General Information of the Compound
| Compound ID |
CP0361809
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(NE)-N-[(3E,5E)-3-[(2-bromo-4,5-dimethoxyphenyl)methylidene]-1-propan-2-yl-5-[(3,5,6-trimethylpyrazin-2-yl)methylidene]piperidin-4-ylidene]hydroxylamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H31BrN4O3
|
||||||||||||||||||
| Molecular Weight |
515.452
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(Br)c(\C=C2/CN(C/C(=C\c3nc(C)c(C)nc3C)/C/2=N/O)C(C)C)cc1OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H31BrN4O3/c1-14(2)30-12-19(8-18-10-23(32-6)24(33-7)11-21(18)26)25(29-31)20(13-30)9-22-17(5)27-15(3)16(4)28-22/h8-11,14,31H,12-13H2,1-7H3/b19-8+,20-9+,29-25+
Show/Hide
|
||||||||||||||||||
| InChIKey |
QLJVUGOZYMSDGQ-WBAKZUHQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell Viability or Cytotoxicity Assay